The therapeutic monitoring of antimicrobial agents. (Q33540451)

27 July 2017

1 reference

title

The therapeutic monitoring of antimicrobial agents. (English)

1 reference

27 July 2017

1

E J Begg

1 reference

27 July 2017

M L Barclay

2

1 reference

PubMed ID

10073735

27 July 2017

C J Kirkpatrick

series ordinal

3

1 reference

PubMed ID

10073735

27 July 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

British Journal of Clinical Pharmacology

27 July 2017

1 reference

27 July 2017

47

1 reference

27 July 2017

1

1 reference

27 July 2017

23-30

1 reference

Therapeutic drug monitoring of systemic antifungal therapy

27 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

The comparative efficacy and safety of teicoplanin and vancomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Vancomycin therapeutic drug monitoring: is it necessary?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Once versus thrice daily gentamicin in patients with serious infections

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Vancomycin toxicity. What is the evidence for dose dependency?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Flucytosine--what is its future?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Aminoglycoside toxicity and relation to dose regimen.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Serum aminoglycoside concentrations: the case for routine monitoring

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Impact of vancomycin therapeutic drug monitoring on patient care

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Pharmacokinetics of vancomycin in patients with various degrees of renal function

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Pharmacokinetics of vancomycin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

A simplified dosing method for initiating vancomycin therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

A Bayesian feedback method of aminoglycoside dosing.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Toxicity of amphotericin B plus flucytosine in 194 patients with cryptococcal meningitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Ketoconazole vs. itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

A prospective randomised trial comparing individualised pharmacokinetic dosage prediction for aminoglycosides with prediction based on estimated creatinine clearance in critically ill patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Individualizing vancomycin dosage regimens: one- versus two-compartment Bayesian models

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Evaluation of a Bayesian method for predicting vancomycin dosing.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Application of a Bayesian method to monitor and adjust vancomycin dosage regimens

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Nephrotoxicity of vancomycin, alone and with an aminoglycoside

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Comparison of vancomycin- and teicoplanin-induced histamine release and "red man syndrome".

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Vancomycin-induced histamine release and "red man syndrome": comparison of 1- and 2-hour infusions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Interaction of Azoles with Rifampin, Phenytoin, and Carbamazepine: In Vitro and Clinical Observations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Bone marrow toxicity associated with 5-fluorocytosine therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Kinetic model for gentamicin dosing with the use of individual patient parameters

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014209

Studies on drug monitoring in thrice and once daily treatment with aminoglycosides

21 June 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00850.X

Ototoxicity induced by once-daily gentamicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00850.X

Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00850.X

Why monitor peak vancomycin concentrations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00850.X

Antibiotic therapy of bacterial endocarditis. VII. Vancomycin for acute micrococcal endocarditis; preliminary report

21 January 2018

1 reference

12 December 2020

Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization

1 reference

12 December 2020

Routine monitoring of serum vancomycin concentrations: waiting for proof of its value

1 reference

12 December 2020

Errors in assuming a one-compartment model for vancomycin

1 reference

12 December 2020

Does accepting pharmacokinetic recommendations impact hospitalization? A cost-benefit analysis

1 reference

12 December 2020

Serum aminoglycoside clearance is predicted as poorly by renal aminoglycoside clearance as by creatinine clearance in critically ill patients

1 reference

12 December 2020

The in-vitro degradation at 37 degrees C of vancomycin in serum, CAPD fluid and phosphate-buffered saline

1 reference

12 December 2020

Evaluation of a method for initiating vancomycin therapy: experience in 205 patients

1 reference

12 December 2020

The in-vitro antifungal spectrum of itraconazole

1 reference

12 December 2020

Experience in monitoring gentamicin therapy during treatment of serious gram-negative sepsis

1 reference

12 December 2020

Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia

1 reference

12 December 2020

How vancomycin is used in Australasia - A survey

1 reference

12 December 2020

Determination of itraconazole and its active metabolite in plasma by column liquid chromatography

1 reference

12 December 2020

Low itraconazole serum concentrations following administration of itraconazole suspension to critically ill allogeneic bone marrow transplant recipients

1 reference

12 December 2020

Therapeutic monitoring of antimicrobials: a summary of the information presented at the UK NEQAS for antibiotic Assays meeting for participants, October 1993

1 reference

12 December 2020

Aminoglycosides--50 years on

1 reference

12 December 2020

Pharmacokinetics of a single dose of teicoplanin in burn patients

1 reference

12 December 2020

Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries

1 reference

12 December 2020

Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00850.X

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference

PubMed ID

10073735